SUVN-G3031
CAS No. 1394808-82-2
SUVN-G3031 ( SUVN-G 3031 )
Catalog No. M11647 CAS No. 1394808-82-2
SUVN-G3031 (SUVN-G 3031) is a potent, selective, orally active histamine H3 receptor (H3R) inverse agonist with Ki of 8.73 nM (hH3R).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 152 | Get Quote |
|
5MG | 260 | Get Quote |
|
10MG | 417 | Get Quote |
|
25MG | 687 | Get Quote |
|
50MG | 963 | Get Quote |
|
100MG | 1287 | Get Quote |
|
500MG | 2601 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSUVN-G3031
-
NoteResearch use only, not for human use.
-
Brief DescriptionSUVN-G3031 (SUVN-G 3031) is a potent, selective, orally active histamine H3 receptor (H3R) inverse agonist with Ki of 8.73 nM (hH3R).
-
DescriptionSUVN-G3031 (SUVN-G 3031) is a potent, selective, orally active histamine H3 receptor (H3R) inverse agonist with Ki of 8.73 nM (hH3R); exhibited an IC50 of 20 nM with progressive inhibition of (R)-α-methylhistamine (0.03 μM) induced agonist activity in [35S]-GTPγS binding assay using CHO-K1 cells expressing human H3R membranes; reverses (R)-α-methylhistamine induced dipsogenia in vivo.Parkinson Disease Phase 1 Clinical
-
SynonymsSUVN-G 3031
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorHistamine Receptor
-
Research AreaNeurological Disease
-
IndicationParkinson Disease
Chemical Information
-
CAS Number1394808-82-2
-
Formula Weight373.50
-
Molecular FormulaC21H31N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)NC(=O)CN4CCOCC4
-
Chemical NameN-[4-(l-Cyclobutylpiperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nirogi R, et al. J Med Chem. 2019 Jan 10. doi: 10.1021/acs.jmedchem.8b01280.
molnova catalog
related products
-
Betazole hydrochlori...
Betazole hydrochloride is an agonist of H2 receptor.
-
Roxatidine Acetate h...
Roxatidine Acetate hydrochloride is a specific and competitive histamin H2-receptor antagonist, with IC50 of 3.2 μM.
-
Astemizole
Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.